Intramuscular corticosteroid injection in hiposteoarthritis: A randomized controlled trial.
Completed
- Conditions
- hiposteoarthritiscorticosteroid injectionintramuscular
- Registration Number
- NL-OMON29422
- Lead Sponsor
- Erasmus MC Rotterdam, Department of General Practice
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 135
Inclusion Criteria
Patients will be recruited from primary care (general practitioner) or secondary care (outpatient orthopedic clinic). They will be eligible if they:
1. Have a diagnosis of OA of the hip according to clinical ACR criteria, including radiologic signs of OA (Kellgren-Lawrence grading equal or greater than 2);
Exclusion Criteria
Patients will be excluded if they have:
1. Inability to understand Dutch questionnaire;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain reduction at 2 weeks follow-up (NRS 0-10, WOMAC pain subscale).
- Secondary Outcome Measures
Name Time Method 1. Pain reduction at 4, 6 and 12 weeks follow-up (NRS, WOMAC pain subscale);<br /><br>2. Effect on function (WOMAC function subscale), mobility (WOMAC stiffness subscale);<br /><br>3. Perceived recovery (7-point Likert scale);<br /><br>4. Response rate according to OARSI/OMERACT criteria;<br /><br>5. Side effects;<br /><br>6. Difference between primary and secondary care setting.